AZD5396 / University of Pennsylvania, Inovio, AstraZeneca, The Wistar Institute, Indiana University  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5396 / Inovio, AstraZeneca
NCT05293249: dMAbs for Prevention of COVID-19

Recruiting
1
50
US
dMAb AZD5396, dMAb AZD8076, CELLECTRA™ 2000 with Side Port needle, OpBlock 0078 Electroporation device, Hylenex, CELLECTRA™ 2000 with Side Port needle, OpBlock 0070 Electroporation device
Pablo Tebas, The Wistar Institute, AstraZeneca, Inovio Pharmaceuticals
Healthy Volunteers
09/25
09/25

Download Options